Intsia Pharma

Chennai, India Founded: 2019 • Age: 7 yrs
Develops and sells branded pharmaceutical drugs for therapeutic needs worldwide.

About Intsia Pharma

Intsia Pharma is a Healthcare company based in Chennai (India) founded in 2019. It develops and sells branded pharmaceutical drugs for therapeutic needs worldwide. It operates on a B2B and D2C model. Its Indian entity Intsia Pharma Private Limited reported revenue of β‚Ή59.4 Lakh. Intsia Pharma offers products and services including Antibiotics, Anti Diabetic Drugs, and Cardiovascular Drugs. Its focus areas include Pharmaceuticals, Nutraceuticals, Health Supplements and Branded Drugs. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Intsia Pharma Private Limited, based in Chennai, India, manufactures and distributes a wide range of branded drugs including antibiotics, anti-diabetics, and cardiovascular medications. They focus on high-quality therapeutic solutions through research and development, serving domestic and international markets. The company provides sterile and non-sterile dosages like tablets and capsules, emphasizing patient safety and effective health outcomes for diverse clientele.

Key Metrics
  • Annual Revenue
    ₹59.4 Lakh

    FY 2024 · +89% YoY

  • Net Profit
    ₹88,352

    FY 2024 · 1% margin

  • EBITDA
    ₹3 Lakh

    FY 2024 · 5% margin

Products & Services of Intsia Pharma

Intsia Pharma offers a comprehensive portfolio of products and services, including Antibiotics, Anti Diabetic Drugs, and Cardiovascular Drugs.

Antibiotics
Pharmaceutical Drugs

Medications for treating bacterial infections effectively

Anti Diabetic Drugs
Pharmaceutical Drugs

Treatments for managing diabetes and blood sugar levels

Cardiovascular Drugs
Pharmaceutical Drugs

Solutions for heart health and related conditions

Board of directors of Intsia Pharma Private Limited (Intsia Pharma)

Intsia Pharma Private Limited is the primary company behind Intsia Pharma. The board of Intsia Pharma Private Limited currently have 2 directors; the longest-serving is Rajendran Kamesh, appointed in 2020. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rajendran Kamesh
DIN 08865221
Managing Director05 Sep 20206 yrs 2 moIntsia Pharma Private Limited
Subramani . Rajendran
DIN 10229757
Director07 Jul 20233 yrs 4 moIntsia Pharma Private Limited

Financials of Intsia Pharma

Figures of Intsia Pharma Private Limited, the primary company behind Intsia Pharma, for FY 2024. Revenue was ₹59.4 Lakh (+89% year on year). Net profit was ₹88,352 (1% margin). EBITDA was ₹3 Lakh (5% margin).

  • ₹59.4 LakhRevenue · FY 2024 · +89% YoY
  • ₹88,352Net profit · 1% margin
  • ₹3 LakhEBITDA · 5% margin
  • ₹1 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Intsia Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Intsia Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Intsia Pharma

Intsia Pharma has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Intsia Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Intsia Pharma (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 55.41 M362
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 56.21 M144
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Intsia Pharma

Intsia Pharma was founded in 2019.

Intsia Pharma is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

The primary company behind Intsia Pharma, Intsia Pharma Private Limited, reported revenue of β‚Ή59.4 Lakh for FY 2024, up 89% year on year.

Intsia Pharma Private Limited, based in Chennai, India, manufactures and distributes a wide range of branded drugs including antibiotics, anti-diabetics, and cardiovascular medications. They focus on high-quality therapeutic solutions through research and development, serving domestic and international markets. The company provides sterile and non-sterile dosages like tablets and capsules, emphasizing patient safety and effective health outcomes for diverse clientele.

Intsia Pharma's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Intsia Pharma offers Antibiotics, Anti Diabetic Drugs, and Cardiovascular Drugs.

Intsia Pharma operates through Intsia Pharma Private Limited.

The legal entities of Intsia Pharma currently have 2 directors, including Subramani . Rajendran, Rajendran Kamesh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available